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During its life cycle, Plasmodium falciparum un-
dergoes rapid proliferation fueled by de novo synthe-
sis and acquisition of host cell lipids. Consistent
with this essential role, Plasmodium lipid synthesis
enzymes are emerging as potential drug targets. To
explore their broader potential for therapeutic inter-
ventions, we assayed the global lipid landscape
during P. falciparum sexual and asexual blood stage
(ABS) development. Using liquid chromatography-
mass spectrometry, we analyzed 304 lipids consti-
tuting 24 classes in ABS parasites, infected red blood
cell (RBC)-derived microvesicles, gametocytes, and
uninfected RBCs. Ten lipid classes were previously
uncharacterized in P. falciparum, and 70%–75% of
the lipid classes exhibited changes in abundance
during ABS and gametocyte development. Utilizing
compounds that target lipidmetabolism, we affirmed
the essentiality of major classes, including triacylgly-
cerols. These studies highlight the interplay between
host and parasite lipid metabolism and provide a
comprehensive analysis of P. falciparum lipids with
candidate pathways for drug discovery efforts.
INTRODUCTION
Symptomatic infection by the malaria parasite Plasmodium is
caused by asexual blood stage (ABS) intra-erythrocytic para-
sites that undergo cycles of invasion, maturation, replication,
and egress. Intra-erythrocytic forms can also enter gametocy-
togenesis, the sexual differentiation pathway (Nilsson et al.,
2015). Gametocytes progress through five morphologically dis-
tinctive stages (I–V) over 10–14 days to become transmissible
to Anopheles mosquito vectors, wherein they undergo fertiliza-
tion and produce infectious sporozoites. Transcriptomic and
proteomic studies have revealed marked differences betweenCell Host &gametocytes and ABS parasites (Pelle et al., 2015; Silvestrini
et al., 2010).
Throughout its life cycle P. falciparum orchestrates a vast
array of lipid-dependent processes, including intracellular sig-
naling, protein trafficking, membrane biogenesis, and hemo-
globin degradation. Studies have shown that lipid synthesis,
uptake, and transport are essential for P. falciparum ABS viability
(Ben Mamoun et al., 2010). Fatty acids (FAs), the building blocks
of lipids, are typically taken up from the human host by ABS par-
asites, in contrast to mosquito-resident stages that require de
novo FA synthesis (van Schaijk et al., 2014). Potent antimalarial
activity has been observed with compounds that target mem-
brane or signaling lipids such as phosphatidylcholine (PC), phos-
phoethanolamine (PE), or phosphatidylinositol (PI) 4-phosphate
(Bobenchik et al., 2013; Gonza´lez-Bulnes et al., 2011; McNa-
mara et al., 2013).
To delineate the repertoire and dynamics of P. falciparum lipid
metabolism, we undertook a comprehensive lipidomics analysis
of ABS parasites, microvesicles derived from infected red blood
cells (RBCs), gametocytes, and host RBCs. This study identifies
potential vulnerabilities that can be leveraged to target malaria
infection and transmission and provides a resource for further
studies of plasmodial lipids and membrane trafficking.
RESULTS
Comparison of Lipids in P. falciparum ABS
and Host RBCs
We measured the relative abundance of 304 lipid species in
highly synchronized Dd2 parasites, harvested every 8 hr post-
invasion (hpi) throughout the 48 hr intra-erythrocytic develop-
mental cycle (IDC). Parasites were isolated following saponin
treatment, which lyses RBCs but leaves parasites intact within
their plasmamembrane. Pelleted parasite samples werewashed
extensively to remove RBC cytosol and membrane. Lipids were
extracted from parasite samples, or control uninfected RBCs,
and subjected to liquid chromatography-mass spectrometry
(LC-MS). Individual lipid species were assigned to three classes:
phospholipids, sphingolipids, and glycerolipids (also referred to
as neutral lipids).Microbe 18, 371–381, September 9, 2015 ª2015 Elsevier Inc. 371
Lipidomic comparison of saponin-lysed parasites and unin-
fected RBCs revealed significant differences in abundance for
nearly all of the detected lipid species (Figures 1 and S1 and
Table S1). Parasite fractions had levels of phosphatidylglycerol
(PG), acyl PG, lysophosphatidylinositol (LPI), bis(monoacylgly-
cero)phosphate (BMP), monosialodihexosyl-ganglioside (GM3),
diacylglycerol (DAG), and triacylglycerol (TAG) at least 2-fold
higher than those of uninfected RBCs (Figure 1). This suggests
that parasites cannot scavenge these lipids without compro-
mising the host and might require de novo synthesis. The other
lipids analyzed either displayed a <2-fold difference (e.g., PI) or
were enriched in uninfected RBCs (e.g., phosphatidylserine
[PS], phosphatidic acid [PA], and ceramide [also known as N-
acyl sphingosine]). Lipids enriched in the host cell may serve
as a reservoir for parasite-mediated salvage. Indeed, prior
studies have shown that P. falciparum can import a number of
lipid species including ceramide, complex sphingolipids, and
Lyso PC (Asahi et al., 2005; Gerold and Schwarz, 2001; Haldar
et al., 1991).
Delineating the Temporal Changes of Lipid Species
throughout the P. falciparum ABS Developmental Cycle
ABS parasites exhibited distinct temporal profiles for all three
major lipid classes. Phospholipids, which principally play a
structural role, remained relatively constant, with few species
changing significantly over time. In contrast, sphingolipid levels
decreased and glycerolipid levels increased as ABS parasites
matured (Figures 1 and S1A–S1C). The greatest number of lipid
species changingR1.5-fold was between 24 and 32 hpi (Figures
S1B and S1C), consistent with rapid growth and increasedmeta-
bolic activity as the parasite transitioned from ring to trophozoite.
Concordant results were observed between our saponin-lysed
parasite samples and magnet-enriched trophozoite samples in
terms of the abundance of individual lipid species and their levels
in parasite versus uninfected RBC samples (Figure S1D).
Phospholipids constituted the major lipid class detected in
parasite fractions, with PC and PE together accounting for
50% of total lipid (Figure 1 and Table S1). A similar finding
was also recently reported in a separate study of saponin-lysed
parasite samples (Botte´ et al., 2013). These structural membrane
components primarily contained two saturated or monosatu-
rated FA chains (PC [34:1], PC [32:0], and PE [34:1]), consistent
with ABS parasites requiring an exogenous supply of oleic (18:1)
and palmitic (16:0) acid to sustain growth (Mi-Ichi et al., 2007).
We also identified five minor phospholipid subclasses, namely
acyl PS, acyl PG, Lyso PI, Lyso PE, and BMP, that were previ-
ously uncharacterized in P. falciparum (Figures 1 and S1).
Lysophospholipids possess only one FA chain and are minor
constituents of cell membranes that in mammalian cells help
regulate diverse processes including cell signaling, protein
folding, and the mobilization of intracellular Ca2+ stores. This
subclass made up less than 1% of total parasite lipids and
changed rapidly throughout the IDC (Figure 1), consistent with
a putative role in intracellular signaling. In cancer lines, Lyso PI
promotes cell proliferation and migration (Grzelczyk and Gen-
daszewska-Darmach, 2013). In P. falciparum, Lyso PI exhibited
a 2-fold increase at 48 hpi, suggesting a potential role in micro-
tubule-mediated migration of the nucleus into budding merozo-
ites or their subsequent release (Taraschi et al., 1998).372 Cell Host & Microbe 18, 371–381, September 9, 2015 ª2015 ElsWealso observed distinct temporal profiles with the previously
uncharacterized phospholipids acyl PS and acyl PG, which
peaked early and late, respectively, in the parasite IDC (Figure 1).
These lipids had previously been observed in murine brain and
bacteria, respectively (Guan et al., 2007; Yagu¨e et al., 1997).
Our in silico analyses (using hidden Markov models) of the
P. falciparum proteome identified 23% amino acid identity be-
tween PF3D7_1212500 and the Arabidopsis thaliana acyltrans-
ferase At1g78690p, which promotes the accumulation of acyl
PG when expressed in Escherichia coli (Garrett and Moncada,
2014). Expression of the PF3D7_1212500 gene peaks at 32 hpi
(Bozdech et al., 2003; www.plasmoDB.org), when acyl PG levels
begin to increase. The low abundance of acyl PG in humans
makes this biosynthetic pathway a potentially attractive target
for therapeutic intervention.
Although previously unidentified in P. falciparum, BMP has
been found in Leishmania, where it is proposed tomediate fusion
of the parasitophorous vacuole membrane and host autophago-
somes (Schaible et al., 1999). In P. falciparum, BMP levels
suddenly increased at 48 hpi, coincident with merozoite release
(Figure 1). We posit that BMP might promote vesicle formation
and membrane fusion and remodeling during merozoite egress.
The second major class of lipids observed was sphingolipids,
which possess a sphingosine backbone linked to FAs via amide
bonds and play critical roles in both membrane structure and
signaling (Gault et al., 2010). Sphingomyelin (SM), a structural
sphingolipid that aids the biogenesis and maintenance of the
tubulovesicular network of membranes (Lauer et al., 1997),
was the third most abundant lipid overall, consistent with other
studies (Botte´ et al., 2013; Macrae et al., 2014) (Figure 1). Like
other structural lipids, SM levels remained relatively static
throughout the IDC (Figure 1). We also detected a previously
uncharacterized structural sphingolipid, dihydrosphingomyelin
(dhSM; Figures 1 and S1).
SM can also serve as a reservoir for the production of ceram-
ides via its hydrolysis by sphingomyelinases. Ceramides are
potent second messengers that regulate diverse processes
including cell death, differentiation, and migration (Hannun and
Obeid, 2011). Maintaining ceramide homeostasis is paramount
for P. falciparum, as either insufficient or excessive ceramide
levels can have deleterious effects (Labaied et al., 2004; Pan-
kova-Kholmyansky et al., 2003). P. falciparum is known to import
ceramides (Haldar et al., 1991); however, the evidence for de
novo synthesis has been scant. We identified dihydroceramides
(dhCer; Figure 1), the biosynthetic precursors of ceramides,
suggesting that P. falciparum may possess the capability to
synthesize ceramide de novo. Ceramides can be modified to
produce gangliosides by the addition of an oligosaccharide
and a sialic acid. Our study also identified the ganglioside
GM3. In humans, gangliosides are concentrated on cell sur-
faces, where they contribute to cellular recognition, cell-to-cell
signaling, and innate immune responses (Ariga et al., 2008).
Further studies are warranted to explore the role of GM3 in
host-parasite interactions.
ABS parasites possess two major glycerolipid species, DAG
and TAG, which consist of a glycerol backbone esterified with
FAs. DAG is a potent second messenger that activates protein
kinase C (Gon˜i and Alonso, 1999) and serves as a precursor for
major phospholipids and TAG. TAG is packaged into cytosolicevier Inc.
Figure 1. Comparative Profiling of Uninfected Host RBCs and P. falciparum ABS Parasites
24 composite lipid species from Dd2 parasites and uninfected human RBCs were quantified via LC-MS/MS. Data are shown asmeans ± SEM (n = 3 independent
experiments performed in triplicate). Uninfected RBCs were harvested at the 48 hr time point. Means and SEM are depicted as solid and dashed red lines,
respectively. Significant differences between uninfected RBCs and saponin-lysed ABS parasite pellets (containing some residual RBC membranes) were
calculated using Student’s t test and are indicated above individual time points; *p % 0.01. Stars beside the names indicate lipid subclasses previously
undocumented in P. falciparum. PC, phosphatidylcholine; PE, phosphatidylethanolamine; PS, phosphatidylserine; PI, phosphatidylinositol; PG, phosphatidyl-
glycerol; BMP, bis(monoacylglyceryl)phosphate; SM, sphingomyelin; dhSM, dihydroSM; Cer, ceramide; dhCer, dihydroCer; LacCer, lactosylCer; GM3, mon-
osialodihexosylganglioside; GLuCer, GlucosylCer; GalCer, GalactosylCer.
Cell Host & Microbe 18, 371–381, September 9, 2015 ª2015 Elsevier Inc. 373
Figure 2. Infected Microvesicles Display a Distinct Lipidomic Profile
27 composite lipid species from uninfected and infected RBC microvesicles
(RMVs) were quantified via LC-MS/MS. Data are shown asmeans ± SEM (n = 3
independent experiments performed in triplicate). Significant difference be-
tween uninfected and infected RMVs was calculated by Student’s t test. *p%
0.05, **p % 0.01. Abbreviations are listed in the Figure 1 legend, with the
following additions: Pep, PE plasmologen; PCe, PC ether; PA, phosphatidic
acid; MAG, monoacylglycerol; Sulf, sulfatide.lipid droplets that detoxify and sequester FAs. In eukaryotic
cells, lipase-mediated TAG degradation releases these FAs,
which can be used for membrane assembly or beta oxidation
(Athenstaedt and Daum, 2006). Both species increased in abun-
dance as the parasite matured (Figure 1B).
Microvesicles Derived from Infected RBCs Display a
Distinct Lipid Profile
We also characterized the lipid profiles of RBC-derived microve-
sicles (RMVs, also referred to as exosome-like vesicles or micro-
particles) purified from infected and uninfected RBCs (Figures 2
and S2). Microvesicles mediate intercellular communication and
the transfer of lipids, cytosolic proteins, and RNA in mammalian
cells (Raposo and Stoorvogel, 2013). Patients infected with
P. falciparum possess elevated levels of RMVs, which have
been implicated in intercellular communication and gametocyto-
genesis (Mantel et al., 2013; Nantakomol et al., 2011; Regev-
Rudzki et al., 2013). RMVs derived from infected RBCs (iRMVs)
were significantly enriched for PS and PI. PS was 2-fold higher
in infected, relative to uninfected, RMVs; this increase appeared
to come primarily at the expense of PC (Figure 2). These data
corroborate previous evidence of elevated PS levels in RMVs
from P. falciparum cultures or plasma of P. falciparum-infected
humans or P. berghei-infected mice (Couper et al., 2010; Mantel
et al., 2013; Nantakomol et al., 2011). RMVs have been proposed
to arise by blebbing from specific subdomains, potentially lipid374 Cell Host & Microbe 18, 371–381, September 9, 2015 ª2015 Elsrafts, within the RBC membrane. P. falciparum-infected RBC
membranes and lipid rafts are both enriched in PS, which could
provide the source of phospholipid detected in these iRMVs
(Mantel et al., 2013; Pattanapanyasat et al., 2010; Salzer and
Prohaska, 2001). iRMVs were also enriched for sphingolipids
including ceramide, lactosylceramide (LacCer), dhCer, and
GM3. Ceramide, LacCer, and GM3 are potent signaling mole-
cules that modify the immune response (Inokuchi et al., 2015;
Maceyka and Spiegel, 2014); these may contribute to the immu-
nomodulatory effects ascribed to P. falciparum iRMVs (Mantel
et al., 2013).
The Antimalarial Agent Orlistat Inhibits the Hydrolysis of
Triacylglycerols
To further probe the contribution of lipid metabolism to Plasmo-
dium ABS viability, we assessed the antiparasitic activity of 21
compounds known to inhibit various lipid metabolic pathways
in other organisms (Table S2). 72 hr growth inhibition studies re-
vealed moderate to potent antimalarial activity for Orlistat and
GW4869 (yielding mean ± SEM IC50 values of 0.9 ± 0.1 mM and
6.0 ± 0.3 nM, respectively).
Orlistat is an irreversible inhibitor of pancreatic lipase, which
hydrolyzes TAGs to a monoglyceride molecule and two FA spe-
cies. This anti-obesity drug is known to inhibit P. falciparum ABS
growth (Yuan et al., 2011; Figure 3A and Table S2). To examine
its stage specificity, we added Orlistat at 83 IC50 to highly syn-
chronized ring-stage Dd2 parasites and monitored development
every 8 hr. Orlistat had no effect on ring to trophozoite progres-
sion, yet dramatically stalled parasite growth at the schizont
stage 48–56 hpi (Figure 3B). The effect was specific, as adding
Orlistat at 48 hpi (after the onset of merozoite formation) did
not prevent merozoite release or RBC reinvasion. This arrest co-
incides with a significant drop in TAG levels at 48 hpi (Figure 1)
and with peak transcription of PF3D7_1427100 that encodes a
putative lipase (Bozdech et al., 2003). The addition of exogenous
oleic acid (18:1) and palmitic acid (16:0) did not rescue Orlistat-
treated parasites (Figure S3A), suggesting that the rapid and
localized intracellular release of FAs is essential for parasite
development late in the ABS cycle.
To directly assess whether Orlistat impacted TAG levels late
during ABS development, we co-incubated synchronized para-
sites, beginning at 6–8 hpi, with 83 IC50 concentrations of
Orlistat as well as the FA tracer [3H]-oleic acid (18:1). Parasites
were then harvested at 24 hpi and 56 hpi time points; at
56 hpi, schizonts had stalled and parasite reinvasion had
not occurred (Figures 3B and 3C). As controls, we used an un-
related drug azithromycin, which targets the apicoplast 50S
ribosomal subunit and causes a delayed death phenotype
(treated parasites die in the subsequent cycle of RBC infection;
Sidhu et al., 2007). Parasites were harvested after 72 hr of expo-
sure, corresponding to 30–32 hpi in the second cycle of growth
and a time at which their development had stalled, as well as
an initial time point of 24 hpi. Using thin-layer chromatography,
TAG levels in drug-treated samples were calculated relative
to DMSO-treated controls. For both Orlistat and azithromycin
at 24 hpi, TAG levels in drug-treated parasites were compa-
rable to those of DMSO-treated controls (Figure 3C). Once par-
asites had stalled, however, Orlistat-treated parasites had sig-
nificantly higher TAG levels than azithromycin-treated parasitesevier Inc.
Figure 3. Orlistat Inhibits Triacylglycerol
Degradation and Merozoite Maturation
(A) Schematic representation of TAG degradation.
TAG is stored in cytosolic lipid droplets (orange)
and can be degraded by lipases to produce DAG
or MAG. Orlistat prevents TAG catabolism by in-
hibiting lipase action.
(B) Highly synchronized ABS parasites (starting at
8 hpi) were serially assessed for development
every 8 hr following the addition of 6 mM Orlistat
(83 IC50), beginning at 8, 16, 24, 32, 40, and 48 hpi.
Once added, Orlistat was maintained until the
final time point at 56 hpi. Giemsa-stained smears
were analyzed by light microscopy (examples
provided), and the experiment was performed on
three separate occasions. Across all experiments,
parasites averaged 2.5%–4% until reinvasion at
48 hr, when untreated parasites reinvaded and
parasitemia climbed to 9%–12%. However, re-
invasion did not occur in Orlistat-treated parasites,
and parasitemias remained at 2%–2.5%.
(C) Synchronized ABS parasites were treated
6–8 hpi with [3H]-oleic acid (18:1) and 83 IC50
concentrations of either Orlistat or the delayed
death inhibitor azithromycin. DMSO was used as
a solvent control. Parasites were harvested after
24 hr. For Orlistat and azithromycin, parasites were
also harvested after a further 24 or 48 hr (corre-
sponding to 54–56 hpi or 78–80 hpi), respectively.
For these agents, parasites haddevelopmentally stalled at the later time points (late in the first and second cycles of growth, respectively). Lipidswere extracted and
subjected to thin-layer chromatography. TAG levels were normalized to DMSO-treated parasites extracted at the corresponding time points and are shown as
means ± SEM (n = 3 independent experiments performed in triplicate).
(D) Percent reinvasion of RBCs after mechanical rupture of synchronized schizont-infected RBCs treated with 1 mM E-64, 125 nM KAI407, or 6 mM (83 IC50)
Orlistat. Data are shown as means ± SEM (from three independent experiments performed in triplicate).
(E) Plasma membrane ingression around developing daughter cells was visualized using the plasma membrane marker PfATP4-GFP (McNamara et al., 2013).
Synchronized parasites were treated at 24 hpi with either 6 mM Orlistat or DMSO and imaged 28 hr later (i.e., 52 hpi). Control parasites had organized and fully
enclosed developing merozoites, whereas plasma membrane ingression was perturbed by Orlistat treatment. Nuclei were stained with Hoechst 33342.(Figure 3C). These data were confirmed in separate experiments
that measured TAG levels by mass spectrometry (Figure S3B).
Our findings are consistent with the hypothesis that parasites
need to hydrolyze TAG to progress late in the ABS cycle.
TAG hydrolysis produces a rapid increase in intracellular FAs
in ABS parasites (Palacpac et al., 2004a). These FAs may pro-
mote the formation of membranes during merozoite maturation,
or due to their detergent-like properties may mediate the rupture
of RBC membranes releasing fully mature merozoites. To
distinguish between these hypotheses, we assessed whether
Orlistat-treated merozoites are viable once released by me-
chanical disruption. We added Orlistat (83 IC50) to a highly syn-
chronized Dd2 culture at 38–40 hpi, prior to maximal TAG
degradation (Figure 1). At 50–56 hpi, the stalled parasites were
mechanically ruptured to release merozoites. As a positive con-
trol, we utilized 1 mM E-64, a cysteine protease inhibitor that
blocks parasite egress but does not prevent reinfection by me-
chanically released merozoites (Boyle et al., 2010; Drew et al.,
2008). As a negative control we used 125 nM of KAI407 (53
IC50), a phosphatidylinositol-4-kinase inhibitor that impairs cyto-
kinesis and causes defective merozoite membrane biogenesis
(McNamara et al., 2013). E-64 and KA1407 were added once
merozoites began to form. As anticipated, E-64-treated para-
sites reinvaded RBCs following rupture, resulting in a parasite-
mia of 3%. In contrast, rupture of Orlistat-treated parasites
yielded a 10-fold lower parasitemia, similar to KAI407-treatedCell Host &parasites (Figure 3D). These data suggest that Orlistat acts prior
to merozoite egress.
To examine whether Orlistat-treated parasites were unable to
form merozoite membranes and therefore mature, we visualized
the invagination of the parasite plasmamembrane around devel-
oping merozoites using the plasma-membrane protein PfATP4-
GFP (Rottmann et al., 2010). Parasites were treated with 6 mM
Orlistat at the 24 hr time point (as in Figure 3B) and imaged after
28 hr of incubation when they had progressed to late schizonts.
DMSO-treated controls displayed complete ingression of the
plasma membrane. In comparison, Orlistat-treated parasites
had disorganized segmentation and lacked fully defined mero-
zoites (representative results shown in Figure 3E). These data
suggest that Orlistat inhibits merozoitematuration prior to egress
and that TAGhydrolysis plays an important role in thismaturation
process.
GW4869 Possesses Potent Antimalarial Activity
Neutral sphingomyelinase (SMase) hydrolyzes sphingomyelin to
produce ceramide in response to cellular stress (Figure 4A).
Neutral SMase activity has been detected in P. falciparum and
is inhibited by low micromolar concentrations of scyphostatin,
a first-generation neutral SMase inhibitor (Hanada et al., 2000).
We tested five newer, structurally different neutral SMase in-
hibitors for inhibition of ABS parasite growth. Among these,
GW4869 had potent antimalarial activity with an IC50 value ofMicrobe 18, 371–381, September 9, 2015 ª2015 Elsevier Inc. 375
Figure 4. GW4869 Interferes with ABS Ceramide Metabolism and
Infected RMV Egress
(A) Schematic representation of the sphingomyelin cycle. Ceramide is pro-
duced via the hydrolysis of sphingomyelin via a neutral sphingomyelinase,
which is inhibited by GW4869.
(B) Dd2 parasites were subjected to 72 hr drug assays with GW4869 ±
50 mg/ml of lignoceric ceramide. Mean ± SEM IC50 values were calculated
from four independent sets of duplicates. **p% 0.01.
(C) Parasite ABS development was assessed following the addition of 1 mM
GW4869 (1703 IC50) to highly synchronized parasites, beginning 8 hpi.
Compound was added at time points 8, 16, 24, 32, 40, or 48 hpi. Giemsa-
stained smears were counted at every time point, as well as the final 56 hpi
time point (experiment performed in duplicate on two separate occasions).
Mean ± SEM parasitemias are shown for the 8 and 56 hpi time points. **p%
0.01.6 nM (Figure 4B and Table S2). This effect was partially rescued
by supplementation of GW4869-treated parasites with exo-
genous lignoceric acid (C24:0) ceramide, the most abundant
ceramide species in P. falciparum ABS parasites (Figure 4B
and Table S1). In control experiments, lignoceric ceramide had
no effect on artemisinin activity (Figure 4B). These data suggest
that GW4869 exerts its antiparasitic activity by inhibiting cer-
amide production.376 Cell Host & Microbe 18, 371–381, September 9, 2015 ª2015 ElsTo determine when parasites are most sensitive to GW8469
treatment, we exposed highly synchronized Dd2 cultures to
1 mM of GW4869 shortly following merozoite invasion and
monitored parasite expansion and development every 8 hpi.
Parasites continued to develop throughout the ABS cycle in
the presence of drug. Significantly fewer drug-treated parasites
were observed after reinvasion (at 56 hpi; Figure 4C). Untreated
control parasites successfully reinvaded and increased the
parasitemia to 12%, a 4-fold increase (at 8 hpi). In our growth
inhibition assays, GW4869 never achieved 100% killing even at
the highest dose of 500 mM. We posit that a small population
of parasites can survive by scavenging ceramide from RBCs,
therefore potentially limiting the utility of SMase inhibitors as
therapeutics.
Lipids Play a Role in Gametocyte Development and
Induction
The switch from the proliferating ABS to the non-proliferating
gametocyte is essential for Plasmodium transmission to the
mosquito vector. To characterize gametocyte lipid metabolism
and how it varies from its asexual precursor, we measured the
relative abundance of lipid species in early- and late-stage ga-
metocytes, shown as log2 fold change from a trophozoite
(32 hpi)-enriched ABS culture (Figures 5A and S4 and Table
S3). We found that the gametocyte lipidome, like its transcrip-
tome and proteome, varies significantly from its ABS precursor.
Approximately 70% of the lipid classes measured exhibited a
significant difference in abundance from 32 hpi trophozoites
(Figure 5A). Moreover, a similar number of lipids also displayed
marked changes in abundance between early- and late-stage
gametocytes, suggesting that lipid metabolic pathways are
active throughout gametocyte maturation.
We observed a general reduction in phospholipid abundance in
gametocytes, with 67% of these lipids significantly reduced in
both early and late stages as compared to ABS trophozoites (Fig-
ure 5A). Lysophospholipids experienced the greatest decrease in
relative abundance, with ether lysophosphatidylcholine (LPCe)
exhibitinga6-fold and4-folddecreaseduringearly and lategame-
tocytogenesis, respectively (Figure 5A). These findings are con-
cordant with transcriptional evidence of upregulation of a putative
lysophospholipase PFI1775W by AP2-G, a master regulator of
gametocyte development (Kafsack et al., 2014). In contrast, PS
exhibited an 8-fold increase in early-stage gametocytes as com-
pared to ABSparasites. This is consistentwith the high level of ex-
pression of the putative PS synthase PF3D7_1366800 throughout
gametocytogenesis (www.plasmoDB.org). Based on these data,
wepropose thatbothPFI1775WandPF3D7_1366800might serve
as potential gametocytocidal targets.
Almost all of the sphingolipids measured exhibited a signifi-
cant increase in relative abundance in gametocytes, with the
exception of GM3. Specifically, we saw a dramatic expansion
in ceramides and complex sphingolipids (Figure 5A). The most
significant change occurred with the ceramide precursor, dhCer,
which increased 4- to 10-fold in early- and late-stage gameto-
cytes, respectively. Increased dhCers in gametocytes suggest
an increased requirement for sphingolipids that cannot be met
by uptake alone.
Conversely, glycerolipids were less abundant in gametocytes
than inABSparasites (Figure5A).TAG inparticularwasdecreasedevier Inc.
Figure 5. Gametocytes Possess a Unique Lipidomic Profile That Contributes to Their Induction and Development
(A) LC-MS/MS was used to quantify 27 lipid classes from saponin-lysed early-stage (stages I–II) and late-stage (stages IV–V) gametocytes, and trophozoites
(32 hpi). The relative abundance of the 27 lipid classes is presented as log2 gametocytes/trophozoites. Data showmeans ± SEM (n = 3 independent experiments
performed in triplicate). Significant differences between trophozoite and gametocytes were calculated using the Student’s t test. *p% 0.05, **p% 0.01.
(B) Cytosolic lipid droplets were stained with BODIPY 493/503 in Dd2 ABS parasites (32 hpi) or gametocytes (early and late stages). Nuclei were stained with
Hoechst 33342. The red arrow indicates the presence of a cytosolic lipid droplet in the 32 hpi trophozoite. Representative images from a single experimental
replicate are shown (n = 2 independent experiments).
(C) Early- or late-stage gametocytes were treated with the indicated compounds for 3 days. IC50 values were calculated based on the quantification of viable
gametocytes by flow cytometry. Data show mean ± SEM IC50 values (n = 3 independent experiments performed in duplicate).
(D) Gametocytes were induced by stressing ABS parasites with atovaquone (1.25 nM for 24 hr), 50% conditioned media (for 24 hr), serine (500 mM for 48 hr),
NNDMS (2 mM for 24 hr), Orlistat (0.8 mM for 24 hr), or media with low FAs (15 mMof each of palmitic and oleic acid). ABS parasites (day 0) and gametocytes (days
10–12) were quantified by flow cytometry. Data are presented as a percent of ABS parasites on day 0 that became gametocytes. Data showmeans ± SEM (n = 3
independent experiments performed in triplicate). **p% 0.01.in both early- and late-stage gametocytes. To assess the status
of lipid droplets, which are TAG-storing organelles, we stained
early- and late-stage gametocytes with BODIPY 493/503, a
glycerolipid-specific dye. We observed distinct foci of BODIPY
staining in trophozoites, indicating the presence of cytosolic lipid
droplets (typically one per parasite). In contrast, BODIPY staining
in early and late gametocytes was diffuse and weak, suggesting
the absence of droplets (Figure 5B). These data suggest that
unlike ABS parasites, gametocytes do not amass TAG stores. In
mammalian cells, lipid droplets can serve as a FA reservoir to
furnish heightened metabolic needs (Barbosa et al., 2015). In ga-
metocytes, however, many of the major structural lipids (i.e., PC,
PE, or SM) were significantly lower or remained constant, sug-
gesting that membrane proliferation or remodeling occur less
than in ABS parasites, thereby decreasing FA requirements.Cell Host &To better understand which lipid metabolic pathways are crit-
ical for gametocyte viability, we tested our panel of 21 lipid-tar-
geting compounds (Table S2) for gametocytocidal activity. The
potent gametocytocidal agent methylene blue was included as
a positive control (Adjalley et al., 2011). Only two of the com-
pounds assayed, GT11 and MSDH-C, exhibited gametocytoci-
dal activity (Figure 5C). Both of these compounds target dhCer
synthase in the de novo ceramide synthesis pathway (Table
S2). These data support our lipidomic findings that ceramide
synthesis increases in gametocytes and may play an essential
role in gametocyte viability.
The physiological mechanism that prompts sexual conversion
of asexual parasites in vivo is undoubtedly multifactorial. Recent
studies have illustrated that one such factor is iRMVs, present in
conditioned medium (Mantel et al., 2013; Regev-Rudzki et al.,Microbe 18, 371–381, September 9, 2015 ª2015 Elsevier Inc. 377
2013). In our studies iRMVs and gametocytes showed similar lip-
idomic profiles. Notably, both were enriched in dhCer, ceramide,
and PS (Figures 2 and 5A). To explore ceramide and PS meta-
bolism in gametocytogenesis, we treated highly synchronized
cultures enriched for rings (with a 3% parasitemia, starting on
day 2) with 500 mM exogenous serine or 2 mM N,N-Dimethyl-
sphingosine (NNDMS). Serine was chosen, as it increases intra-
cellular levels of certain phospholipids (including PS and PE) and
sphingolipids (Elabbadi et al., 1997; Slotte, 2013). We selected
NNDMS, as it targets ceramide metabolism in ABS parasites
by decreasing ceramide catabolism to sphingosine-1-phos-
phate (S1P; see below). This most likely occurs via the docu-
mented ability of NNDMS to inhibit sphingosine kinases that
convert sphingosine to S1P (Igarashi et al., 1990). As an unre-
lated control drug, we used atovaquone, an inhibitor of cyto-
chrome B in the parasite mitochondrion. As a positive control,
we supplemented an 8%–10% ring-stage parasite culture with
50% conditioned media, which is a standard means of inducing
gametocytes (Fivelman et al., 2007). Upon reinvasion (day 0), all
cultures were also treated with 50 mM N-acetyl glucosamine
(NAG) for 4–6 days to eliminate ABS parasites. We observed
significantly more gametocytes in low-density cultures supple-
mented with exogenous serine than in high-parasitemia cultures
treated with 50% conditioned media (Figure 5D). Furthermore,
the addition of NNDMS to low-density cultures induced a num-
ber of gametocytes comparable to that inducedwith conditioned
media treatment (Figure 5D). Our mass spectrometry studies
also revealed that early- to mid-stage gametocytes contain low
levels of S1P as compared to asexual ring-stage parasites.
These studies identified mean ± SEM levels of 2,128 ± 468 pico-
moles of S1P/mg of total parasite protein for untreated gameto-
cytes, as compared with 4,471 ± 737 for NNDMS-treated ABS
parasites and 9,911 ± 3,295 for untreated ABS parasites (S1P
levels compared with untreated ABS parasites were significantly
different for both other groups; see Supplemental Information).
Those studies corroborate the importance of diverting ceramide
away from its catabolism to S1P (via sphingosine). Collectively,
these data suggest that manipulating sphingolipids and phos-
pholipid metabolic pathways may shift the balance toward
gametocytogenesis.
We next asked whether modifying glycerolipid metabolism in
ABS parasites might increase gametocytogenesis. This was
prompted by our observations of increased gametocytemia in
cultures treated with the TAG lipase inhibitor Orlistat. Similar to
the experiments described above, we treated a highly synchro-
nized culture enriched for rings (3% parasitemia) with 800 nM
Orlistat for 24 hr. This treatment produced equivalent numbers
of gametocytes compared to cultures treated with 50% condi-
tioned media (Figure 5D). This result suggests that inhibiting
the mobilization of FA stores from lipid droplets in ABS parasites
favors sexual-stage development. This corroborates a prior
study demonstrating that disruption of an ATP-binding cassette
transporter, ABCG2, in ABS parasites decreased glycerolipids
and promoted gametocytogenesis (Tran et al., 2014). In eukary-
otes, lipid droplets protect against cell death during times of
nutrient deprivation by providing FAs to meet the metabolic
and energy needs of the cell (Cabodevilla et al., 2013). We
conjecture that the inability of Orlistat-treated ABS parasites to
access their reserve stores of FAsmimics a FA deficit, and there-378 Cell Host & Microbe 18, 371–381, September 9, 2015 ª2015 Elsfore a nutrient-poor environment, stimulating gametocytogene-
sis. Consistent with this possibility, we observed that exposing
ABS parasites to diminished exogenous FA levels by culturing
with 15 mM palmitic acid (C16:0) and oleic acid (C18:1) in the
absence of human serum or Albumax produced significantly
more gametocytes than our 50% conditioned media positive
control (Figure 5D).
DISCUSSION
Our lipidomic analysis has identified lipid classes that were pre-
viously uncharacterized in P. falciparum. These lipids include 6
phospholipid (lyso PE, lyso PI, ether lyso PC, acyl PG, acyl PS,
and BMP) and 4 sphingolipid (dhSM, dhCer, GM3, and sulfati-
des) classes. Overall, 75%of the detected lipid classes exhibited
significant changes in abundance throughout the ABS life cycle,
with 9 lipids exhibiting a change greater than 2-fold. Further-
more, a majority of the lipids measured are abundant in the
RBC, providing a potential pool of lipids that can be scavenged
by the parasite.
One important extrapolation from our data is that lipid meta-
bolism in P. falciparum is not insular, but is instead dynamically
intertwined with that of its host. This was exemplified by our
studies with GW4869, which inhibits the parasite’s ability to pro-
duce ceramide via the hydrolysis of sphingomyelin. GW4869
failed to kill 100% of parasites even at 1703 IC50, and supple-
mentation with exogenous ceramide further countered the ef-
fects of the compound. We estimate that ceramide makes up
3.5% of total host RBC lipids, i.e., 10 times more than that
found in the parasite. While GW4869 clearly had potent antima-
larial activity, we posit that a small population of parasites sur-
vived by acquiring ceramide from the host. Therefore, the neutral
SMase pathway alone is likely not a primary candidate for future
antimalarial drug discovery work.
In contrast, our analysis identified four lipid classes, TAG,
DAG, PG, and acyl PG, as potential limiting factors for parasite
survival. Each demonstrated a significant increase in abundance
throughout the ABS cycle, suggesting their importance in para-
site growth and development. Equally notable, these lipids are
not abundant in the RBC, preventing the parasite from scav-
enging these lipids without cannibalizing its host. Previous un-
successful attempts to genetically disrupt the TAG biosynthetic
pathway (Palacpac et al., 2004b) corroborate our studies with
Orlistat, indicating the importance of TAG metabolism to para-
site development. Our findings with GW4869 and Orlistat high-
light the necessity to understand the interplay between host
and parasite lipid metabolic networks when assessing the ther-
apeutic potential of a lipid-targeting drug. In this case, although
Orlistat (IC50 0.9 mM) is less potent than GW4869 (IC50 6 nM), it is
arguably a better drug candidate as it targets the metabolic
pathway of a lipid that cannot be scavenged.
To identify lipid metabolic pathways that may serve as game-
tocytocidal targets, we profiled the lipidome of early-stage
(stages I–II) and late-stage (stages IV–V) gametocytes. Overall,
70% of the lipid classes under investigation varied significantly
in abundance between early and late stages, suggesting that
lipid metabolic pathways are active throughout sexual-stage
maturation. A similar number of differences were observed be-
tween gametocytes and ABS parasites. Specifically, we foundevier Inc.
that relative to the trophozoite, both early- and late-stage game-
tocytes were enriched for sphingolipids involved in ceramide
metabolism while possessing fewer phospholipids and glycero-
lipids. These data were corroborated by our finding that MSDH-
C and GT11, inhibitors of the ceramide biosynthetic pathway,
killed gametocytes with an IC50 in the 1–2 mM range. Neither
compound was active against ABS parasites, highlighting the
singular importance of de novo synthesis of ceramides to game-
tocyte viability. The antimalarial GW869, which inhibits a neu-
tral SMase, had no effect on gametocytes. This suggests that
perhaps the primary pathway for ceramide production in game-
tocytes has shifted away from sphingomyelin hydrolysis to de
novo synthesis of ceramide.
Multiple factors likely contribute to the onset of gametocyto-
genesis. Our lipidomics analysis revealed that gametocytes are
highly enriched for PS and ceramides, while having lower levels
of glycerolipids. Consequently, we hypothesized that these
pathways may play a role in creating a lipid environment that
favors gametocyte induction. Our studies show that the addition
of serine or NNDMS, which increases various phospholipids
and sphingolipids, can increase gametocyte induction. Exoge-
nous serine may promote gametocytogenesis via the perturba-
tion of phospholipid or sphingolipid pathways. Treatment of
parasites with NNDMS also resulted in increased gametocyte
numbers and decreased S1P levels, evoking a potential role
for ceramide metabolism in gametocytogenesis. We have also
shown that altering glycerolipid metabolism, by treating with
Orlistat or depleting levels of exogenous FAs, increases gameto-
cytemia. These data indicate that lipid depletion, including FA
constituents, might be an important cue for gametocytogenesis
commitment.
With malaria still a leading cause of infectious disease
morbidity and mortality, it is essential that we define core fea-
tures of Plasmodium biology. The ability to generate concurrent
lipidomic, transcriptomic, and proteomic profiles will allow us
to dissect metabolic networks that underlie the molecular
etiology of malaria, as an approach to expanding our therapeutic
armamentarium.
EXPERIMENTAL PROCEDURES
P. falciparum Asexual Blood-Stage Cultures and Synchronization
and Saponin Lysis
Parasites were maintained in human RBCs in RPMI 1640 complete medium
containing 10% human serum or 0.5% Albumax (for NF54 and Dd2 strains,
respectively). Strains were synchronized with 5% D-sorbitol (w/v) for two or
more successive growth cycles and expanded to 8%–10% parasitemia
prior to harvesting. For lipid analysis, 75 ml cultures were prepared at
8%–10% parasitemia and 4%–6% hematocrit. Cultures were centrifuged
and the medium removed. Cell pellets were resuspended in 40 ml of 13
PBS buffer with 0.1% saponin and incubated for 10–15 min. Cells were
then recentrifuged to pellet the parasites, colored brown because of the in-
ternal hemozoin. A white layer of RBC membrane that sediments above the
parasite pellets was carefully removed along with the supernatant. Parasite
pellets (typically 0.5–1.0 ml) were washed an additional 3–4 times with
15 ml 13 PBS buffer. These washes removed residual hemoglobin and
RBC membrane, ensuring a minimal RBC component in the final saponin-
lysed parasite fraction.
Gametocyte Commitment and Harvesting
To produce gametocytes, 300 ml cultures of ABS NF54 parasites were doubly
synchronized with 5% D-sorbitol (w/v) treatment. 2%–3% synchronous tro-Cell Host &phozoites were incubated overnight to obtain 8%–10% ring-stage parasites.
Cultures were stressed by replacing 50% of the spent medium with fresh me-
dium (resulting in ‘‘50% conditioned media’’). On the next day (day 1), when
parasites reached the trophozoite stage, the medium was changed and cul-
tures were diluted 2-fold. On the following day, day 0, 50 mMN-acetyl glucos-
amine (NAG) was added to ring-stage parasites and maintained for 2–3 cycles
to eliminate ABS forms. Immature gametocytes (stages I–II) andmature game-
tocytes (stages IV–V) were harvested on days 2–4 and 10–12, respectively.
Harvested cultures were lysed with 0.01% saponin, washed 3–4 times with
13 PBS, and frozen. Gametocytemias at time of harvest were 3%–4%.
Analysis of Lipids Using High-Performance Liquid
Chromatography-Mass Spectrometry
Lipids were extracted from uninfected RBCs, RBC microvesicles, Dd2
parasites, and gametocytes, as described (Hara and Radin, 1978). Briefly,
2 ml of isopropanol: hexane (1:2) and 2ml of KCl (2M): MeOH (4:1) were added
to cell pellets. Samples were mixed and centrifuged at 4,000 RPM for 5 min.
The organic (top) layer was removed and the pellet was re-extracted with
2 ml of isopropanol: hexane (1:2). The organic phase was dried with nitrogen
gas and resuspended in 500 ml hexane (Tinkelenberg et al., 2000). Samples
were dried down again with nitrogen gas and resuspended in 300 ml
chloroform: methanol (2:1). Lipid extracts were analyzed using a 6490 Triple
Quadrupole LC/MS system and were spiked with appropriate internal stan-
dards. Glycerophospholipids and sphingolipids were separated with normal-
phase HPLC. An Agilent Zorbax Rx-Sil was used under the following con-
ditions: mobile phase A (chloroform: methanol: 1 M ammonium hydroxide,
89.9:10:0.1, v/v) andmobile phase B (chloroform:methanol: water: ammonium
hydroxide, 55:39.9:5:0.1, v/v); 95% A for 2 min, linear gradient to 30% A over
18 min and held for 3 min, and linear gradient to 95% A over 2 min and held
for 6 min. Sterols and glycerolipids were separated with reverse-phase
HPLC using an isocratic mobile phase with an Agilent Zorbax Eclipse XDB-
C18 column (4.63 100 mm). Quantification of lipid species was accomplished
using multiple reaction monitoring (MRM) transitions. Expanded procedures
are described in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
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http://dx.doi.org/10.1016/j.chom.2015.08.003.
AUTHOR CONTRIBUTIONS
Conceived and designed the experiments: S.G., E.H.E., D.A.F. Performed the
experiments: S.G., R.B.C., B.J., B.Z., P.-Y.M., M.C.S.L., N.S., O.C.-F., D.H.,
T.S.W. Analyzed the data: S.G., E.H.E., K.V.R., D.A.F. Wrote the paper: S.G.,
D.A.F., with input from other authors. All authors approved the final
manuscript.
ACKNOWLEDGMENTS
Funding for this work was provided by the NIH (R01 AI085584 and R01
AI103058 to D.A.F), a postdoctoral award fromNovartis for P.-Y.M., and a Bur-
roughs Wellcome carrier development award for M.M.
Received: December 16, 2014
Revised: June 29, 2015
Accepted: August 13, 2015
Published: September 9, 2015
REFERENCES
Adjalley, S.H., Johnston, G.L., Li, T., Eastman, R.T., Ekland, E.H., Eappen,
A.G., Richman, A., Sim, B.K., Lee, M.C., Hoffman, S.L., and Fidock, D.A.
(2011). Quantitative assessment of Plasmodium falciparum sexual develop-
ment reveals potent transmission-blocking activity by methylene blue. Proc.
Natl. Acad. Sci. USA 108, E1214–E1223.Microbe 18, 371–381, September 9, 2015 ª2015 Elsevier Inc. 379
Ariga, T., McDonald, M.P., and Yu, R.K. (2008). Role of ganglioside meta-
bolism in the pathogenesis of Alzheimer’s disease–a review. J. Lipid Res.
49, 1157–1175.
Asahi, H., Kanazawa, T., Hirayama, N., and Kajihara, Y. (2005). Investigating
serum factors promoting erythrocytic growth of Plasmodium falciparum.
Exp. Parasitol. 109, 7–15.
Athenstaedt, K., and Daum, G. (2006). The life cycle of neutral lipids: synthesis,
storage and degradation. Cell. Mol. Life Sci. 63, 1355–1369.
Barbosa, A.D., Savage, D.B., and Siniossoglou, S. (2015). Lipid droplet-organ-
elle interactions: emerging roles in lipid metabolism. Curr. Opin. Cell Biol. 35,
91–97.
BenMamoun, C., Prigge, S.T., and Vial, H. (2010). Targeting the lipidmetabolic
pathways for the treatment of malaria. Drug Dev. Res. 71, 44–55.
Bobenchik, A.M., Witola, W.H., Augagneur, Y., Nic Lochlainn, L., Garg, A.,
Pachikara, N., Choi, J.Y., Zhao, Y.O., Usmani-Brown, S., Lee, A., et al.
(2013). Plasmodium falciparum phosphoethanolamine methyltransferase is
essential for malaria transmission. Proc. Natl. Acad. Sci. USA 110, 18262–
18267.
Botte´, C.Y., Yamaryo-Botte´, Y., Rupasinghe, T.W., Mullin, K.A., MacRae, J.I.,
Spurck, T.P., Kalanon, M., Shears, M.J., Coppel, R.L., Crellin, P.K., et al.
(2013). Atypical lipid composition in the purified relict plastid (apicoplast) of
malaria parasites. Proc. Natl. Acad. Sci. USA 110, 7506–7511.
Boyle, M.J., Wilson, D.W., Richards, J.S., Riglar, D.T., Tetteh, K.K., Conway,
D.J., Ralph, S.A., Baum, J., and Beeson, J.G. (2010). Isolation of viable
Plasmodium falciparum merozoites to define erythrocyte invasion events
and advance vaccine and drug development. Proc. Natl. Acad. Sci. USA
107, 14378–14383.
Bozdech, Z., Llina´s, M., Pulliam, B.L., Wong, E.D., Zhu, J., and DeRisi, J.L.
(2003). The transcriptome of the intraerythrocytic developmental cycle of
Plasmodium falciparum. PLoS Biol. 1, E5.
Cabodevilla, A.G., Sa´nchez-Caballero, L., Nintou, E., Boiadjieva, V.G.,
Picatoste, F., Gubern, A., and Claro, E. (2013). Cell survival during complete
nutrient deprivation depends on lipid droplet-fueled b-oxidation of fatty acids.
J. Biol. Chem. 288, 27777–27788.
Couper, K.N., Barnes, T., Hafalla, J.C., Combes, V., Ryffel, B., Secher, T.,
Grau, G.E., Riley, E.M., and de Souza, J.B. (2010). Parasite-derived plasmami-
croparticles contribute significantly to malaria infection-induced inflammation
through potent macrophage stimulation. PLoS Pathog. 6, e1000744.
Drew, M.E., Banerjee, R., Uffman, E.W., Gilbertson, S., Rosenthal, P.J., and
Goldberg, D.E. (2008). Plasmodium food vacuole plasmepsins are activated
by falcipains. J. Biol. Chem. 283, 12870–12876.
Elabbadi, N., Ancelin, M.L., and Vial, H.J. (1997). Phospholipid metabolism of
serine in Plasmodium-infected erythrocytes involves phosphatidylserine and
direct serine decarboxylation. Biochem. J. 324, 435–445.
Fivelman, Q.L., McRobert, L., Sharp, S., Taylor, C.J., Saeed, M., Swales, C.A.,
Sutherland, C.J., and Baker, D.A. (2007). Improved synchronous production of
Plasmodium falciparum gametocytes in vitro. Mol. Biochem. Parasitol. 154,
119–123.
Garrett, T.A., and Moncada, R.M. (2014). The Arabidopsis thaliana lysophos-
pholipid acyltransferase At1g78690p acylates a variety of lysophospholipids
including bis(monoacylglycero)phosphate. Biochem. Biophys. Res. Commun.
452, 1022–1027.
Gault, C.R., Obeid, L.M., and Hannun, Y.A. (2010). An overview of sphingolipid
metabolism: from synthesis to breakdown. Adv. Exp. Med. Biol. 688, 1–23.
Gerold, P., and Schwarz, R.T. (2001). Biosynthesis of glycosphingolipids de-
novo by the human malaria parasite Plasmodium falciparum. Mol. Biochem.
Parasitol. 112, 29–37.
Gon˜i, F.M., and Alonso, A. (1999). Structure and functional properties of diac-
ylglycerols in membranes. Prog. Lipid Res. 38, 1–48.
Gonza´lez-Bulnes, P., Bobenchik, A.M., Augagneur, Y., Cerdan, R., Vial, H.J.,
Llebaria, A., and Ben Mamoun, C. (2011). PG12, a phospholipid analog with po-
tent antimalarial activity, inhibits Plasmodium falciparum CTP:phosphocholine
cytidylyltransferase activity. J. Biol. Chem. 286, 28940–28947.380 Cell Host & Microbe 18, 371–381, September 9, 2015 ª2015 ElsGrzelczyk, A., and Gendaszewska-Darmach, E. (2013). Novel bioactive glyc-
erol-based lysophospholipids: new data – new insight into their function.
Biochimie 95, 667–679.
Guan, Z., Li, S., Smith, D.C., Shaw, W.A., and Raetz, C.R. (2007). Identification
of N-acylphosphatidylserine molecules in eukaryotic cells. Biochemistry 46,
14500–14513.
Haldar, K., Uyetake, L., Ghori, N., Elmendorf, H.G., and Li, W.L. (1991). The
accumulation and metabolism of a fluorescent ceramide derivative in
Plasmodium falciparum-infected erythrocytes. Mol. Biochem. Parasitol. 49,
143–156.
Hanada, K., Mitamura, T., Fukasawa, M., Magistrado, P.A., Horii, T., and
Nishijima, M. (2000). Neutral sphingomyelinase activity dependent on Mg2+
and anionic phospholipids in the intraerythrocytic malaria parasite Plasmodium
falciparum. Biochem. J. 346, 671–677.
Hannun, Y.A., and Obeid, L.M. (2011). Many ceramides. J. Biol. Chem. 286,
27855–27862.
Hara, A., and Radin, N.S. (1978). Lipid extraction of tissues with a low-toxicity
solvent. Anal. Biochem. 90, 420–426.
Igarashi, Y., Kitamura, K., Toyokuni, T., Dean, B., Fenderson, B., Ogawass, T.,
and Hakomori, S. (1990). A specific enhancing effect of N,N-dimethylsphingo-
sine on epidermal growth factor receptor autophosphorylation. Demonstration
of its endogenous occurrence (and the virtual absence of unsubstituted sphin-
gosine) in human epidermoid carcinoma A431 cells. J. Biol. Chem. 265, 5385–
5389.
Inokuchi, J., Nagafuku, M., Ohno, I., and Suzuki, A. (2015). Distinct selectivity
of gangliosides required for CD4+ T and CD8+ T cell activation. Biochim.
Biophys. Acta 1851, 98–106.
Kafsack, B.F., Rovira-Graells, N., Clark, T.G., Bancells, C., Crowley, V.M.,
Campino, S.G., Williams, A.E., Drought, L.G., Kwiatkowski, D.P., Baker,
D.A., et al. (2014). A transcriptional switch underlies commitment to sexual
development in malaria parasites. Nature 507, 248–252.
Labaied, M., Dagan, A., Dellinger, M., Ge`ze, M., Ege´e, S., Thomas, S.L., Wang,
C., Gatt, S., and Grellier, P. (2004). Anti-Plasmodium activity of ceramide ana-
logs. Malar. J. 3, 49.
Lauer, S.A., Rathod, P.K., Ghori, N., and Haldar, K. (1997). A membrane
network for nutrient import in red cells infected with the malaria parasite.
Science 276, 1122–1125.
Maceyka, M., and Spiegel, S. (2014). Sphingolipid metabolites in inflammatory
disease. Nature 510, 58–67.
Macrae, J.I., Lopaticki, S., Maier, A.G., Rupasinghe, T., Nahid, A., Cowman,
A.F., and McConville, M.J. (2014). Plasmodium falciparum is dependent on
de novo myo-inositol biosynthesis for assembly of GPI glycolipids and infec-
tivity. Mol. Microbiol. 91, 762–776.
Mantel, P.Y., Hoang, A.N., Goldowitz, I., Potashnikova, D., Hamza, B.,
Vorobjev, I., Ghiran, I., Toner, M., Irimia, D., Ivanov, A.R., et al. (2013).
Malaria-infected erythrocyte-derived microvesicles mediate cellular commu-
nication within the parasite population and with the host immune system.
Cell Host Microbe 13, 521–534.
McNamara, C.W., Lee,M.C., Lim, C.S., Lim, S.H., Roland, J., Nagle, A., Simon,
O., Yeung, B.K., Chatterjee, A.K., McCormack, S.L., et al. (2013). Targeting
Plasmodium PI(4)K to eliminate malaria. Nature 504, 248–253.
Mi-Ichi, F., Kano, S., and Mitamura, T. (2007). Oleic acid is indispensable for
intraerythrocytic proliferation of Plasmodium falciparum. Parasitology 134,
1671–1677.
Nantakomol, D., Dondorp, A.M., Krudsood, S., Udomsangpetch, R.,
Pattanapanyasat, K., Combes, V., Grau, G.E., White, N.J., Viriyavejakul, P.,
Day, N.P., and Chotivanich, K. (2011). Circulating red cell-derived microparti-
cles in human malaria. J. Infect. Dis. 203, 700–706.
Nilsson, S.K., Childs, L.M., Buckee, C., and Marti, M. (2015). Targeting human
transmission biology for malaria elimination. PLoS Pathog. 11, e1004871.
Palacpac, N.M., Hiramine, Y., Mi-ichi, F., Torii, M., Kita, K., Hiramatsu, R.,
Horii, T., and Mitamura, T. (2004a). Developmental-stage-specific triacylgly-
cerol biosynthesis, degradation and trafficking as lipid bodies in Plasmodium
falciparum-infected erythrocytes. J. Cell Sci. 117, 1469–1480.evier Inc.
Palacpac, N.M., Hiramine, Y., Seto, S., Hiramatsu, R., Horii, T., and Mitamura,
T. (2004b). Evidence that Plasmodium falciparum diacylglycerol acyltransfer-
ase is essential for intraerythrocytic proliferation. Biochem. Biophys. Res.
Commun. 321, 1062–1068.
Pankova-Kholmyansky, I., Dagan, A., Gold, D., Zaslavsky, Z., Skutelsky, E.,
Gatt, S., and Flescher, E. (2003). Ceramide mediates growth inhibition of the
Plasmodium falciparum parasite. Cell. Mol. Life Sci. 60, 577–587.
Pattanapanyasat, K., Sratongno, P., Chimma, P., Chitjamnongchai, S.,
Polsrila, K., and Chotivanich, K. (2010). Febrile temperature but not proinflam-
matory cytokines promotes phosphatidylserine expression on Plasmodium
falciparum malaria-infected red blood cells during parasite maturation.
Cytometry A 77, 515–523.
Pelle, K.G., Oh, K., Buchholz, K., Narasimhan, V., Joice, R., Milner, D.A.,
Brancucci, N.M., Ma, S., Voss, T.S., Ketman, K., et al. (2015). Transcriptional
profiling defines dynamics of parasite tissue sequestration during malaria
infection. Genome Med. 7, 19.
Raposo, G., and Stoorvogel, W. (2013). Extracellular vesicles: exosomes, mi-
crovesicles, and friends. J. Cell Biol. 200, 373–383.
Regev-Rudzki, N., Wilson, D.W., Carvalho, T.G., Sisquella, X., Coleman, B.M.,
Rug, M., Bursac, D., Angrisano, F., Gee, M., Hill, A.F., et al. (2013). Cell-cell
communication between malaria-infected red blood cells via exosome-like
vesicles. Cell 153, 1120–1133.
Rottmann, M., McNamara, C., Yeung, B.K., Lee, M.C., Zou, B., Russell, B.,
Seitz, P., Plouffe, D.M., Dharia, N.V., Tan, J., et al. (2010). Spiroindolones,
a potent compound class for the treatment of malaria. Science 329, 1175–
1180.
Salzer, U., and Prohaska, R. (2001). Stomatin, flotillin-1, and flotillin-2 aremajor
integral proteins of erythrocyte lipid rafts. Blood 97, 1141–1143.
Schaible, U.E., Schlesinger, P.H., Steinberg, T.H., Mangel, W.F., Kobayashi,
T., and Russell, D.G. (1999). Parasitophorous vacuoles of Leishmania mexi-
cana acquire macromolecules from the host cell cytosol via two independent
routes. J. Cell Sci. 112, 681–693.Cell Host &Sidhu, A.B., Sun, Q., Nkrumah, L.J., Dunne, M.W., Sacchettini, J.C., and
Fidock, D.A. (2007). In vitro efficacy, resistance selection, and structural
modeling studies implicate the malarial parasite apicoplast as the target of azi-
thromycin. J. Biol. Chem. 282, 2494–2504.
Silvestrini, F., Lasonder, E., Olivieri, A., Camarda, G., van Schaijk, B., Sanchez,
M., Younis Younis, S., Sauerwein, R., and Alano, P. (2010). Protein export
marks the early phase of gametocytogenesis of the human malaria parasite
Plasmodium falciparum. Mol. Cell. Proteomics 9, 1437–1448.
Slotte, J.P. (2013). Biological functions of sphingomyelins. Prog. Lipid Res. 52,
424–437.
Taraschi, T.F., Trelka, D., Schneider, T., and Matthews, I. (1998). Plasmodium
falciparum: characterization of organelle migration during merozoite morpho-
genesis in asexual malaria infections. Exp. Parasitol. 88, 184–193.
Tinkelenberg, A.H., Liu, Y., Alcantara, F., Khan, S., Guo, Z., Bard, M., and
Sturley, S.L. (2000). Mutations in yeast ARV1 alter intracellular sterol distribu-
tion and are complemented by human ARV1. J. Biol. Chem. 275, 40667–
40670.
Tran, P.N., Brown, S.H., Mitchell, T.W., Matuschewski, K., McMillan, P.J., Kirk,
K., Dixon, M.W., and Maier, A.G. (2014). A female gametocyte-specific ABC
transporter plays a role in lipid metabolism in the malaria parasite. Nat.
Commun. 5, 4773.
van Schaijk, B.C., Kumar, T.R., Vos, M.W., Richman, A., van Gemert, G.J., Li,
T., Eappen, A.G., Williamson, K.C., Morahan, B.J., Fishbaugher, M., et al.
(2014). Type II fatty acid biosynthesis is essential for Plasmodium falciparum
sporozoite development in the midgut of Anopheles mosquitoes. Eukaryot.
Cell 13, 550–559.
Yagu¨e, G., Segovia, M., and Valero-Guille´n, P.L. (1997). Acyl phosphatidylgly-
cerol: amajor phospholipid ofCorynebacterium amycolatum. FEMSMicrobiol.
Lett. 151, 125–130.
Yuan, J., Cheng, K.C., Johnson, R.L., Huang, R., Pattaradilokrat, S., Liu, A.,
Guha, R., Fidock, D.A., Inglese, J., Wellems, T.E., et al. (2011). Chemical
genomic profiling for antimalarial therapies, response signatures, and molec-
ular targets. Science 333, 724–729.Microbe 18, 371–381, September 9, 2015 ª2015 Elsevier Inc. 381
